Blog

Debunked: Economic Argument against MR-Guided Focused Ultrasound

Written by Mark Carol, MD
Published:
In this blog post, Mark Carol, MD, a senior consultant at the Foundation, addresses a common misconception about the facility costs of focused ultrasound treatments. Learn why most focused ultrasound procedures are a more profitable use of MRI machines for hospitals than diagnostic studies.
Read More ...
Mark Carol, MD

Why It Takes So Long to Develop a Medical Technology (Part 7)

Written by Mark Carol, MD
Published:
Facilities – In this seventh blog in the series, Mark Carol, MD, a senior consultant at the Foundation, addresses how hospitals influence the commercialization of a new medical device. Some of the factors discussed include decisions to invest in new technologies and proper cost reporting to secure adequate payment codes.
Read More ...
Mark Carol, MD

Blog: Gene Therapy and Rare Disease

Written by Bob Smith
Published:
Bob Smith is an accomplished biopharmaceutical executive with over 30 years of experience. He leads Pfizer’s Gene Therapy and Rare Disease portfolio. This blog has been adapted from Mr. Smith’s recorded presentation for the 2022 Symposium.
Read More ...
Bob Smith

European Medical Device Regulation: Amendment Expected to Mitigate Urgent Issues

Written by Thomas Andreae, PhD
Published:
The European medtech community and regulatory bodies have struggled to implement recent medical device regulations. Last month, the EU Commission proposed amendments aimed at alleviating the bottleneck issues. Thomas Andreae, PhD, the Foundation’s focused ultrasound ambassador, Europe, discusses the amendments’ implications in a new blog post.
Read More ...
Why It Takes So Long to Develop a Medical Technology (Part 5) Why It Takes So Long to Develop a Medical Technology (Part 4) Best Practices for Patent Portfolio Impact – How to Patent Patent Strategy for Business Advantage: Insights for Focused Ultrasound Manufacturers Why It Takes So Long to Develop a Medical Technology (Part 3)